Manufacturer record
Medipol Pharmaceutical India Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by Medipol Pharmaceutical India Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between June 2019 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
15 records linked to Medipol Pharmaceutical India Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Noscapine, Chlorpheniramine Maleate, Guaiphenesin & Sodium Citrate Syrup | NGC-091Mfg 2023-12 · Exp 2025-11 | DescriptionDescription | CDL KolkataCDSCO lab | Dec 2024 |
| Clarithromycin Tablets IP 500 mg | TCRM-010Mfg 2023-11 · Exp 2025-10 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2024 |
| Multivitamin with Ascorbic acid syrup 200ml | MVS-005Mfg 2023-04 · Exp 2025-03 | Assay of Thiamine Hydrochlorid eAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Omeprazole Capsules IP | CO40-001Mfg 2020-06 · Exp 2022-05 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Omeprazole Capsules IP | CO40-002Mfg 2020-06 · Exp 2022-05 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Clopidogrel & Aspirin Tablets I.P. | TACB-017Mfg 2020-05 · Exp 2022-04 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jan 2022 |
| Clopidogrel & Aspirin Tablets | TACB-011Mfg 2019-07 · Exp 2021-06 | Disintegration, free salicylic acid & Assay of AspirinAssay | CDTL MumbaiCDSCO lab | May 2021 |
| Clopidogrel & Aspirin Tablets | TACB-013Mfg 2019-07 · Exp 2021-06 | Free salicylic acid, Disintegration, Assay of AspirinAssay | CDTL MumbaiCDSCO lab | Jan 2021 |
| Amitriptyline Tablets I.P. | TAMF-026Mfg 2020-03 · Exp 2022-02 | DescriptionDescription | CDL KolkataCDSCO lab | Jan 2021 |
| Pheniramine Maleate Tablets I.P. | TPNM-003Mfg 2018-12 · Exp 2020-11 | DescriptionDescription | CDL KolkataCDSCO lab | Nov 2020 |
| Clopidogrel & Aspirin Tablets | TACB-010Mfg 2019-07 · Exp 2021-06 | Description, Limit of Salicylic Acid and Assay of aspirinAssay | CDL KolkataCDSCO lab | Sep 2020 |
| Alprazolam Tablets IP | TAZP-003Mfg 2018-12 · Exp 2020-11 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2020 |
| Prednisolone Tablets I.P. | TPR5-033Mfg 2019-04 · Exp 2021-03 | Related Substances and AssayAssay | CDL KolkataCDSCO lab | Apr 2020 |
| Alprazolam tablets I.P. | TAZP-001Mfg 2018-11 · Exp 2020-10 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Aug 2019 |
| Alprazolam Tablets I.P. | TAZP-002Mfg 2018-11 · Exp 2020-10 | Test for DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.